Recent Updates
Recently added Catalysts
ALVO Negative Sentiment Score: 20/100

Alvotech Investigated For Potential Securities Law Violations by Block & Leviton LLP; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Key Takeaway: Alvotech (NASDAQ: ALVO) is under investigation by Block & Leviton for possible securities law violations after the FDA issued a complete response letter regarding its Biologics License Application for the biosimilar candidate AVT02. The CRL cited manufacturing deficiencies as a reason for the application's rejection, which has significantly impacted Alvotech's stock price, causing a more than 20% drop. Investors who have lost money in Alvotech's stock are encouraged to contact the firm for potential recovery options.

Market Sentiment Analysis

CONCERNS & RISKS

  • Alvotech is being investigated for potential securities law violations.
  • The FDA issued a complete response letter for Alvotech's biosimilar application.
  • Deficiencies in Alvotech's manufacturing facility led to the CRL.
  • Shares of Alvotech dropped more than 20% following the news.

Full Press Release Details

BOSTON, April 14, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Alvotech (NASDAQ: ALVO) for potential securities law violations. Investors who have lost money in their Alvotech investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/alvo.
What is this all about?
On April 13, 2023, after the market closed, “Teva Pharmaceutical Industries Ltd. (TEVA) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to its partner Alvotech (ALVO) for the Biologics License Application (BLA) for AVT02, a high-concentration biosimilar candidate for Humira® (adalimumab). The CRL stated that the application could not be approved at this time based on deficiencies associated with Alvotech’s manufacturing facility that must be satisfactorily resolved. Additional review of the details following the recent FDA’s re-inspection and CRL are being assessed to determine next steps.”
Shares of Alvotech dropped more than 20% in early morning trading on April 14, 2023.
Anyone who purchased Alvotech stock and has lost money may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at cases@blockleviton.com, or by phone at (617) 398-5600.
Why should you contact Block & Leviton?
Many law firms may issue press releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email cases@blockleviton.com with any questions.
This notice may constitute attorney advertising.
260 Franklin St., Suite 1860
Phone: (617) 398-5600
SOURCE: Block & Leviton LLP

Tags

Frequently Asked Questions

What is the investigation about Alvotech?

Block & Leviton is investigating Alvotech for potential securities law violations.

Why did Alvotech's shares drop recently?

Alvotech's shares fell over 20% after the FDA issued a complete response letter on AVT02.

How can I recover losses from Alvotech investments?

Investors can contact Block & Leviton to explore options for recovering losses.

What should I do if I lost money on Alvotech stock?

Contact Block & Leviton via their website or phone to learn about recovery options.

What distinguishes Block & Leviton from other firms?

Block & Leviton actively litigates securities class actions and seeks significant recoveries.

Last updated: Apr 14, 2023